VAERS reports by lot

GSK Varicella/Shingles lot 5777F: VAERS reports

47 VAERS reports list lot 5777F as a GSK Varicella/Shingles vaccine, received between 2023-04-10 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
47
Reports
4%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction8646%
General / Systemic (non-local)3217%
Neurological2011%
Dermatological (non-injection-site)179%
Musculoskeletal95%
Gastrointestinal74%
Cardiac / Cardiovascular63%
Allergic / Anaphylactic53%
Psychiatric / Neuropsychiatric32%
Respiratory21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas17
Florida13
New Mexico3
Louisiana2
Maryland2
Missouri2
Virginia1
Georgia1
Minnesota1
Tennessee1
Iowa1
South Carolina1

Reports by month received

2023-044
2023-054
2023-0610
2023-074
2023-081
2023-091
2023-103
2023-121
2024-011
2024-0618

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.